High levels of CCL21 are associated with persisting pulmonary impairment post-COVID-19 hospital admission [28], and CCL21 is recognized for its involvement in recruiting CCR7+ T cells to secondary lymphoid organs, orchestrating the adaptive immune response [29]. This evidence concerns the gene CCL21 and COVID-19.